COMMODORE CAPITAL LP – Karyopharm Therapeutics Inc. Transaction History
COMMODORE CAPITAL LP portfolio value:
$10.56M
portfolio value
COMMODORE CAPITAL LP quarter portfolio value change:
+21.06%
quarter
Karyopharm Therapeutics Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.83M | $5.46 | 1.93M | |
| Q2 2022 | share | Decrease | -45.65% | -1.62M shares | -17.51M | $4.51 | 1.93M |
| Q1 2022 | share | Increase | 0.00% | 3.56M shares | 26.24M | $7.37 | 3.56M |